AstraZeneca will outsource Crestor API following UK plant closure
The closure of an API plant in the UK will lead to opportunities for third party manufacturers, AstraZeneca has said.
The closure of an API plant in the UK will lead to opportunities for third party manufacturers, AstraZeneca has said.
British Airways and Iberia’s cargo division IAG has become the first airline to be awarded accreditation under new EU Good Distribution Practices (GDP) guidelines.
PPD’s biotech company X-Chem has licensed a second drug discovery program to Bayer Pharma, which follows on a multi-target collaboration the companies established in 2012.